aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Quanta Therapeutics, founded in 2018 and based in San Francisco, CA, is a biotechnology company focused on developing novel cancer therapeutics. The company's core mission is to uncover and develop allosteric modulators that target driver oncogenes, specifically RAS mutations, which are implicated in nearly one-quarter of all cancers. Quanta's innovative approach aims to create best-in-class allosteric inhibitors for difficult-to-treat cancers, including pancreatic, colorectal, lung, and endometrial cancers.
Quanta Therapeutics has attracted notable investors and industry leaders due to its groundbreaking work in KRAS therapy. The company’s key achievements include the development of allosteric small molecules targeting previously undruggable RAS mutations such as KRAS G12D and KRAS G12V. By focusing on these challenging targets, Quanta aims to significantly impact the treatment landscape for various aggressive cancers, potentially improving outcomes for many patients worldwide.
Operating Status
Active
Ownership Type(s)
Venture Capital, Equity
Main Product(s)
Cancer Therapeutics
Technology
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Quanta Therapeutics founded?
Quanta Therapeutics was founded in 2018.
Where is Quanta Therapeutics's headquarters located?
Quanta Therapeutics's headquarters is located in San Francisco, CA, US.
When was Quanta Therapeutics's last funding round?
Quanta Therapeutics's most recent funding round was for $50.7M (USD) in May 2023.
How many employees does Quanta Therapeutics have?
Quanta Therapeutics has 28 employees as of Feb 5, 2024.
How much has Quanta Therapeutics raised to-date?
As of July 05, 2023, Quanta Therapeutics has raised a total of $140.7M (USD) since May 22, 2023.
Add Comparison
Total Raised to Date
$140.7M
USD
Last Update May 22, 2023
Last Deal Details
$50.7M
USD
May 22, 2023
Series D
Total Employees Over Time
28
As of Feb 2024
Quanta Therapeutics Address
455 Mission Bay Blvd. South
Rm 322
San Francisco,
California
94158
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts